<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">29269707</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>26</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2186-1005</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>24</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Aug</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia</Title>
          <ISOAbbreviation>Ann Thorac Cardiovasc Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A Case of Paraneoplastic Limbic Encephalitis in a Patient with Invasive Thymoma with Anti-Glutamate Receptor Antibody-Positive Cerebrospinal Fluid: A Case Report.</ArticleTitle>
        <Pagination>
          <StartPage>200</StartPage>
          <EndPage>204</EndPage>
          <MedlinePgn>200-204</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.5761/atcs.cr.17-00135</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Thymoma is known to cause autoimmune neuromuscular disease. However, anti-glutamate receptor antibody limbic encephalitis (LE) with thymoma is relatively rare.</AbstractText>
          <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 68-year-old woman was admitted with progressive memory impairment and personality change. Brain magnetic resonance imaging (MRI) revealed high intensity in the bilateral limbic areas on T2-weighted fluid-attenuation inversion recovery (FLAIR) images. Chest computed tomography revealed a mass in the anterior mediastinum. Surgical resection of the tumor, which was consistent with a type B3 thymoma, resulted in clinical improvement. After surgery, the cerebrospinal fluid (CSF) was found to be positive for anti-N-methyl-D-aspartate (NMDA) type glutamate receptor antibodies. These findings led to the diagnosis of paraneoplastic LE (PLE) associated with thymoma.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">When a patient presents with neurologic symptoms of unknown origin, the possibility of LE accompanied by thymoma should be considered. Rapid treatment is desirable before the symptoms become irreversible.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Inoue</LastName>
            <ForeName>Takuya</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Fukushima Red Cross Hospital, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chest Surgery, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kanno</LastName>
            <ForeName>Ryuzo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Fukushima Red Cross Hospital, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moriya</LastName>
            <ForeName>Arata</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Fukushima Red Cross Hospital, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakamura</LastName>
            <ForeName>Koichiro</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Fukushima Red Cross Hospital, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watanabe</LastName>
            <ForeName>Yuzuru</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Fukushima Red Cross Hospital, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chest Surgery, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsumura</LastName>
            <ForeName>Yuki</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Thoracic Surgery, Fukushima Red Cross Hospital, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Chest Surgery, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suzuki</LastName>
            <ForeName>Hiroyuki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Chest Surgery, Fukushima Medical University School of Medicine, Fukushima, Fukushima, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ann Thorac Cardiovasc Surg</MedlineTA>
        <NlmUniqueID>9703158</NlmUniqueID>
        <ISSNLinking>1341-1098</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016194">Receptors, N-Methyl-D-Aspartate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName>
          <QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020363" MajorTopicYN="N">Limbic Encephalitis</DescriptorName>
          <QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016194" MajorTopicYN="N">Receptors, N-Methyl-D-Aspartate</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013934" MajorTopicYN="N">Thymectomy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013945" MajorTopicYN="N">Thymoma</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013964" MajorTopicYN="N">Thyroid Neoplasms</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">anti-glutamate receptor antibody</Keyword>
        <Keyword MajorTopicYN="N">limbic encephalitis</Keyword>
        <Keyword MajorTopicYN="N">paraneoplastic syndrome</Keyword>
        <Keyword MajorTopicYN="N">thymoma</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29269707</ArticleId>
        <ArticleId IdType="pmc">PMC6102601</ArticleId>
        <ArticleId IdType="doi">10.5761/atcs.cr.17-00135</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jeong JW, Kim KW, Lee DY, et al. 
A normative study of the revised hasegawa dementia scale: comparison of demographic influences between the revised hasegawa dementia scale and the mini-mental status examination. Dement Geriatr Cogn Disord
2007; 24: 288-93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17717415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marx A, Strobel P, Badve S, et al. 
Type B3 thymoma. In: Travis WD, Brambilla E, Burke A, Mark A, Nicholson A. eds; WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: International Agency for Research on Cancer (IARC) Press, 2015; pp 202-4.</Citation>
        </Reference>
        <Reference>
          <Citation>Gultekin SH, Rosenfeld MR, Voltz R, et al. 
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain
2000; 123: 1481-94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10869059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graus F, Delattre JY, Antoine JC, et al. 
Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatr
2004; 75: 1135-40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1739186</ArticleId>
            <ArticleId IdType="pubmed">15258215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ances BM, Vitaliani R, Taylor RA, et al. 
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain
2005; 128: 1764-77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1939694</ArticleId>
            <ArticleId IdType="pubmed">15888538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darnell RB, Posner JB.
Paraneoplastic syndromes involving the nervous system. N Engl J Med
2003; 349: 1543-54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14561798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takashi I, Akio K, Yuichi H.
A paradigm shift in autoimmune encephalopathy. Neurol Therap
2016; 33: 94-8.</Citation>
        </Reference>
        <Reference>
          <Citation>Hisashi M. [Structure and function of divert glutamate receptor channels.] Seikagaku
2005; 77: 619-29. (in Japanese)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16114844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalmau J, Tüzün E, Wu HY, et al. 
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol
2007; 61: 25-36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2430743</ArticleId>
            <ArticleId IdType="pubmed">17262855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Titulaer MJ, McCracken L, Gabilondo I, et al. 
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol
2013; 12: 157-65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3563251</ArticleId>
            <ArticleId IdType="pubmed">23290630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujii N, Furuta A, Yamaguchi H, et al. 
Limbic encephalitis associated with recurrent thymoma: a postmortem study. Neurology
2001; 57: 344-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11468328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohshita T, Kawakami H, Maruyama H, et al. 
Voltage-gated potassium channel antibodies associated limbic encephalitis in a patient with invasive thymoma. J Neurol Sci
2006; 250: 167-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17028029</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
